BAYLOR SCOTT & WHITE - BUDA — History
CCN 670131 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$24M
Latest Revenue (FY2022)
+27.8%
Revenue CAGR (3yr)
-20.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $22M | $24M | +9.7% | +27.8% |
| Operating Expenses | $23M | $27M | $29M | +7.4% | +11.9% |
| Operating Margin | -57.7% | -23.4% | -20.9% | +10.8% | +0.0% |
| Net Income | $-9M | $-5M | $-5M | +2.2% | +0.0% |
| Licensed Beds | 15 | 15 | 15 | +0.0% | +0.0% |
| Total Patient Days | 1,326 | 1,254 | 1,043 | -16.8% | -11.3% |
| Medicare Day % | 23% | 23% | 28% | +19.4% | +10.1% |
| Medicaid Day % | 1% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +63.4% ($15M → $24M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+27.8%
This Hospital
+7.6%
State Avg
Latest Margin
-20.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $29M | -2.5% |
| FY2024 (proj) | $34M | 15.9% |
| FY2025 (proj) | $38M | 34.3% |